Sanara Medtech Inc (SMTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,179 | -2,971 | -1,837 | -2,836 | -1,358 |
| Depreciation Amortization | 210 | 128 | 54 | 120 | 73 |
| Accounts receivable | -536 | -112 | 59 | -324 | -39 |
| Accounts payable and accrued liabilities | -63 | -198 | -48 | -65 | -186 |
| Other Working Capital | -476 | -480 | -707 | 262 | -236 |
| Other Operating Activity | 1,601 | 901 | 447 | 676 | 412 |
| Operating Cash Flow | $-3,443 | $-2,732 | $-2,032 | $-2,167 | $-1,334 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -58 | -58 | -58 | -183 | -167 |
| Net Acquisitions | N/A | N/A | N/A | 509 | 509 |
| Purchase Of Investment | -500 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -1,100 | -1,100 | -500 | -1,523 | -1,023 |
| Other Investing Activity | -1,100 | -1,100 | -500 | -1,524 | -1,024 |
| Investing Cash Flow | $-1,658 | $-1,158 | $-558 | $-1,197 | $-682 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 0 | 0 | 2,200 | 2,000 |
| Debt Issued | 583 | 583 | N/A | N/A | N/A |
| Common Stock Issued | 26 | N/A | N/A | 10,000 | N/A |
| Other Financing Activity | 0 | 0 | 0 | -2,400 | 0 |
| Financing Cash Flow | $609 | $583 | $N/A | $9,800 | $2,000 |
| Beginning Cash Position | 6,612 | 6,612 | 6,612 | 176 | 176 |
| End Cash Position | 2,120 | 3,305 | 4,023 | 6,612 | 161 |
| Net Cash Flow | $-4,492 | $-3,307 | $-2,590 | $6,436 | $-16 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,443 | -2,732 | -2,032 | -2,167 | -1,334 |
| Capital Expenditure | -58 | -58 | -58 | -183 | -167 |
| Free Cash Flow | -3,501 | -2,790 | -2,090 | -2,350 | -1,501 |